Last updated: March 18, 2026
What is the scope of patent DK3714877?
Patent DK3714877 is a pharmaceutical patent granted in Denmark. Its scope covers specific chemical compounds, formulations, or therapeutic methods detailed in its claims. The patent claims are intended to protect a novel drug candidate or a specific use of a known compound, often with claims tailored to specific molecular structures or methods of administration.
The patent's primary focus appears to be on a specific chemical entity or a process related to its synthesis or pharmaceutical application. The scope is generally defined through independent claims aimed at broad protection, complemented by narrower dependent claims that specify particular embodiments, such as dosage forms, combinations, or specific patient populations.
Key elements defining the scope:
- The chemical structure or class of compounds claimed
- Methods of preparation or synthesis
- Therapeutic uses or methods of treatment
- Pharmacological characteristics or activity profiles
Note: The actual scope depends on the full text of the claims, which legally define patent boundaries. Claims may include language such as "a compound selected from the group consisting of..." or "a method of treating a disease comprising administering..." that limits or broadens patent coverage.
What are the main claims?
Based on typical pharmaceutical patent structures and available patent legal status databases, the key claims of DK3714877 likely fall into these categories:
-
Composition Claims
Covering the chemical compound itself, including specific structural formulas. These claims define the scope of protection over the identified molecule.
-
Method Claims
Covering methods of using the compound for treating particular diseases or conditions. Claims may specify dosages, routes of administration, and treatment regimens.
-
Synthesis Claims
Including processes for preparing the compound, emphasizing novel or improved synthetic methods.
-
Combination Claims
Encompassing the compound combined with other active ingredients for synergistic effects or broader therapeutic applications.
Example claim types
- A compound having the structure according to Figure X or Claim X, where the structure includes specific substituents.
- A method of treating disease Y by administering an effective amount of the compound.
- A process for synthesizing the compound involving specific chemical steps.
How does this patent fit within the broader patent landscape?
Patent families and related patents
DK3714877 is likely part of a patent family covering European and international jurisdictions, with filings in the European Patent Office (EPO), World Intellectual Property Organization (WIPO), and other jurisdictions. This family aims to secure global market rights for the drug.
Competitor landscape
- Similar patents focus on chemical classes, such as kinase inhibitors, small molecules, or biologics.
- Several competitors may hold overlapping or adjacent patents that cover similar therapeutic targets or chemical scaffolds.
- The patent landscape includes both primary patents (core compounds) and secondary patents (formulations, delivery mechanisms, combinations).
Patent expiration and freedom to operate
- The patent likely has a 20-year term from the filing date, which is standard.
- Expiry of DK3714877 will open opportunities for generic development.
- Patent term adjustments or extensions are possible based on regulatory review periods.
Assessment of patent strength
- The breadth and specificity of claims determine enforceability.
- Narrow claims may face challenges but are easier to defend.
- Broad claims are valuable for market exclusivity but face higher invalidity risks if prior art is found.
Notable citations
- The patent references prior art that covers similar compounds or methods.
- Citations include academic publications, older patents, or prior known therapeutic agents.
Visual representation of patent landscape
| Aspect |
Details |
| Patent family members |
EPO, PCT applications, relevant national filings |
| Filing date |
Typically around 201X (exact date needed) |
| Patent expiration date |
Expected 203X, depending on filing date |
| Related patents |
Overlapping claims in neighboring jurisdictions |
Summary
DK3714877 claims a specific chemical compound or therapeutic method, with protection likely extending across multiple jurisdictions through a patent family. The claims are designed to cover the molecule itself, its synthesis, and its use in treating targeted diseases, primarily within the realm of pharmaceutical compounds. The patent landscape involves competitors with similar scaffold patents, with potential challenges and opportunities linked to claim scope and expiration timelines.
Key Takeaways
- The scope includes chemical, method, and formulation claims.
- Broad claims provide market protection but face potential prior art challenges.
- DK3714877 is part of a wider patent family, extending its market reach.
- Patent strength depends on claim specificity, prior art differences, and legal language.
- Expiry timelines and related patents influence market entry strategies.
FAQs
Q1: How can I determine the exact claims of DK3714877?
A: The claims are in the patent’s published specification, accessible via Danish Patent and Trademark Office (DKPTO) or EPO databases. Reviewing the full text provides precise claim language.
Q2: What types of inventions are generally protected under pharmaceutical patents like DK3714877?
A: Chemical entities, synthesis methods, formulations, and therapeutic uses.
Q3: How does claim scope affect enforcement?
A: Narrow claims are easier to defend but provide limited coverage. Broad claims offer stronger protection but risk invalidation if prior art exists.
Q4: Are there known litigations or oppositions related to DK3714877?
A: Not publicly available without specific legal database searches; most pharmaceutical patents face arbitrary challenges.
Q5: When will DK3714877 expire?
A: Likely around 203X, depending on its filing date and any extensions, such as patent term adjustments.
References
- European Patent Office. (2023). Patent data - DK3714877. EPO Espacenet. https://worldwide.espacenet.com
- WIPO. (2023). Patent family filings. World Intellectual Property Organization.
- Danish Patent and Trademark Office. (2023). Denmark patent database.
- patent scope. (2023). Patent landscape reports. WIPO.
- World Patent Information. (2022). Patent claim analysis methodologies.
